Announced Sat, 25 Jul · 12:21 IST
Mercury Labs Q1 FY27 Results: PAT Rs 12.47 lakh, clean audit review
Results View source PDF
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve
Awaiting price reaction for this filing.
AI summary
Mercury Laboratories posted unaudited Q1 FY27 results for the quarter ended June 30, 2026. Revenue from operations stood at about Rs 579 lakh. Net profit after tax was Rs 12.47 lakh versus Rs 9.99 lakh in the year-ago quarter, a growth of around 25 percent. Statutory auditors Naresh and Co. issued an unmodified limited review report with no qualifications or concerns flagged. The company operates in a single segment, pharmaceutical products.
Likely market impact
Modest profit growth in Q1 with clean audit review; small-cap pharma with thin liquidity.